Schedule 13G ownership disclosure

APTEVO THERAPEUTICS INC

Common Stock · CUSIP: 03835L504

Event date: 2025-10-31

Filing-level shares
86.00
Percent of class
0.0%
  • BANK OF AMERICA CORP /DE/

    Shares: 86.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000070858-25-000408
Form type
SCHEDULE 13G/A
Filer
Aptevo Therapeutics Inc.
CIK
CIK 1671584
Filed
Nov 07, 2025
Reporting period
Oct 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub